The Lancet (British edition), 2020-02, Vol.395 (10223), p.473-475
2020
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- Ist Teil von
- The Lancet (British edition), 2020-02, Vol.395 (10223), p.473-475
- Ort / Verlag
- England: Elsevier Ltd
- Erscheinungsjahr
- 2020
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0140-6736eISSN: 1474-547XDOI: 10.1016/S0140-6736(20)30317-2Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7134694
- Format
- –
- Schlagworte
- Antibodies, Avascular necrosis, Bacterial infections, Betacoronavirus, Biomedical materials, Children, Clinical trials, Complications, Coronavirus Infections - drug therapy, Coronaviruses, Corticoids, Corticosteroids, COVID-19, COVID-19 Drug Treatment, Diabetes, Diabetes mellitus, Epidemics, Equivalence, Evidence-Based Medicine - methods, Fever, Glucocorticoids - adverse effects, Glucocorticoids - therapeutic use, Humans, Hydrocortisone, Infections, Inflammation, Influenza, Injury analysis, Lungs, Mental disorders, Mortality, Necrosis, Osteoporosis, Patients, Pneumonia, Viral - drug therapy, Psychosis, Randomization, Respiratory diseases, Respiratory distress syndrome, Respiratory syncytial virus, Respiratory therapy, Ribonucleic acid, RNA, SARS-CoV-2, Sepsis, Severe acute respiratory syndrome, Systematic review, Ventilators, Viremia, Viruses